Regulation of fatty acid synthase expression by cholesterol in human cultured cells

Biochemical and Biophysical Research Communications
Y KawabeT Kodama

Abstract

The regulation of fatty acid synthase (FAS) expression by sterols in a cultured human hepatoblastoma cell line, Hep G2, was studied. When cells were treated with compactin in a medium containing lipoprotein deficient serum, FAS mRNA level increased 1.6-fold. A squalene synthase inhibitor, TAN1607A, decreased both free and esterified cholesterol contents in Hep G2 cells and increased mRNA levels for FAS, HMG-CoA reductase, squalene synthase and LDL receptor. However, for the increment of FAS mRNA, a 10-fold higher concentration of this inhibitor was needed. These results demonstrate that the concentration of cellular cholesterol which regulates FAS expression is necessarily lower than the levels which regulate other sterol sensitive genes. FAS mRNA was also increased by an inhibitor of SREBP degradation as well as chenodeoxycholic acid. These results indicate that FAS mRNA expression is regulated by cholesterol and is mediated through SREBPs. The implications of the different modes of sterol regulation of FAS and LDL receptor expression are discussed.

Citations

Jan 1, 1997·Annual Review of Cell and Developmental Biology·C S HwangM D Lane
May 29, 2012·Biochemical Pharmacology·Emmanuelle Plée-GautierLaurent Corcos
Apr 4, 1998·The American Journal of Cardiology·H N Ginsberg
Jun 27, 2002·Biochemical and Biophysical Research Communications·Masaaki NagaiTeruo Ono
Oct 25, 1996·The Journal of Biological Chemistry·R SatoM Maeda
Jan 5, 2000·Physiological Reviews·G J Schroepfer
May 23, 2001·Archives of Biochemistry and Biophysics·S S WolfM Schweizer
Dec 6, 1997·Current Opinion in Genetics & Development·T M Loftus, M D Lane
Jun 11, 1997·European Journal of Pharmacology·T FujiokaH Shimotsu

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.